VExUS in Ards Patients and Association with AKI
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
A single-center prospective observational study will be conducted with the aim of determining the prevalence of venous congestion during ARDS using venous Doppler and the VExUS score.
Eligibility criteria
Qualifiers
Patients ≥18 years old
Moderate to severe ARDS according to the Berlin definition
Requiring catecholamine support
Undergoing invasive mechanical ventilation for less than 48 hours
Disqualifiers
Patients presenting with acute kidney injury KDIGO III requiring renal replacement therapy before the initial ultrasound evaluation
Requirement for veno-venous or veno-arterial ECMO circulatory support before inclusion
Patients with end-stage chronic kidney disease, on dialysis, and/or kidney transplant recipients
History of Child C cirrhosis and/or liver transplantation and/or portal hypertension
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov